The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Meis1 is an essential and rate-limiting regulator of MLL leukemia stem cell potential
Open accessAbstract
Oncogenic mutations of the MLL histone methyltransferase confer an unusual ability to transform non-self-renewing myeloid progenitors into leukemia stem cells (LSCs) by mechanisms that remain poorly defined. Misregulation of Hox genes is likely to be critical for LSC induction and maintenance but alone it does not recapitulate the phenotype and biology of MLL leukemias, which are clinically heterogeneous—presumably reflecting differences in LSC biology and/or frequency. TALE (three-amino-acid loop extension) class homeodomain proteins of the Pbx and Meis families are also misexpressed in this context, and we thus employed knockout, knockdown, and dominant-negative genetic techniques to investigate the requirements and contributions of these factors in MLL oncoprotein-induced acute myeloid leukemia. Our studies show that induction and maintenance of MLL transformation requires Meis1 and is codependent on the redundant contributions of Pbx2 and Pbx3. Meis1 in particular serves a major role in establishing LSC potential, and determines LSC frequency by quantitatively regulating the extent of self-renewal, differentiation arrest, and cycling, as well as the rate of in vivo LSC generation from myeloid progenitors. Thus, TALE proteins are critical downstream effectors within an essential homeoprotein network that serves a rate-limiting regulatory role in MLL leukemogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells.
Park, I.-K., Qian, D., Kiel, M., Becker, M. W., Pihalja, M., Weissman, I. L., Morrison, S. J., & Clarke, M. F. (2003) · Nature · doi:10.1038/nature01587 · Cited by 1,871
Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M. (1999) · Nature · doi:10.1038/16476 · Cited by 1,580
Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9
Krivtsov, A. V., Twomey, D., Feng, Z., Stubbs, M. C., Wang, Y., Faber, J., Levine, J. E., Wang, J., Hahn, W. C., Gilliland, D. G., et al. (2006) · Nature · doi:10.1038/nature04980 · Cited by 1,513 · cited 1×
“This paradigm, however, may not apply to all myeloid leukemias, as suggested by recent studies using a mouse model of AML induced by the MLL-AF9 oncogene (Krivtsov et al. 2006; Somervaille and Cleary 2006), which is typically associated with FAB-M4 or M5 subtypes of human AML (Swansbury 1998).”
Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
Lessard, J., & Sauvageau, G. (2003) · Nature · doi:10.1038/nature01572 · Cited by 1,452
Altered Hox expression and segmental identity in Mll-mutant mice
Yu, B. D., Hess, J. L., Horning, S. E., Brown, G. A. J., & Korsmeyer, S. J. (1995) · Nature · doi:10.1038/378505a0 · Cited by 875
hDOT1L Links Histone Methylation to Leukemogenesis
Okada, Y., Feng, Q., Lin, Y., Jiang, Q., Li, Y., Coffield, V. M., Su, L., Xu, G., & Zhang, Y. (2005) · Cell · doi:10.1016/j.cell.2005.02.020 · Cited by 804
Yokoyama, A., Somervaille, T. C. P., Smith, K. S., Rozenblatt-Rosen, O., Meyerson, M., & Cleary, M. L. (2005) · Cell · doi:10.1016/j.cell.2005.09.025 · Cited by 688
Self-citationHoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
Kroon, E., Krosl, J., Thorsteinsdottir, U., Baban, S., Buchberg, A. M., & Sauvageau, G. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3714 · Cited by 640
Cre-lox-regulated conditional RNA interference from transgenes
Ventura, A., Meissner, A., Dillon, C. P., McManus, M., Sharp, P. A., Van Parijs, L., Jaenisch, R., & Jacks, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403954101 · Cited by 625
Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia
Somervaille, T. C. P., & Cleary, M. L. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.08.020 · Cited by 582
Self-citationGene expression profiling of pediatric acute myelogenous leukemia
Ross, M. E., Mahfouz, R., Onciu, M., Liu, H.-C., Zhou, X., Song, G., Shurtleff, S. A., Pounds, S., Cheng, C., Ma, J., et al. (2004) · Blood · doi:10.1182/blood-2004-03-1154 · Cited by 448
Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9
Ayton, P. M., & Cleary, M. L. (2003) · Genes & Development · doi:10.1101/gad.1111603 · Cited by 436
Self-citationLavau, C. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4226 · Cited by 400
Pbx proteins display hexapeptide-dependent cooperative DNA binding with a subset of Hox proteins.
Chang, C. P., Shen, W. F., Rozenfeld, S., Lawrence, H. J., Largman, C., & Cleary, M. L. (1995) · Genes & Development · doi:10.1101/gad.9.6.663 · Cited by 388
Self-citationGlobal and Hox-specific roles for the MLL1 methyltransferase
Guenther, M. G., Jenner, R. G., Chevalier, B., Nakamura, T., Croce, C. M., Canaani, E., & Young, R. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503072102 · Cited by 357
Ferrando, A. A., Armstrong, S. A., Neuberg, D. S., Sallan, S. E., Silverman, L. B., Korsmeyer, S. J., & Look, A. T. (2003) · Blood · doi:10.1182/blood-2002-10-3221 · Cited by 353
Hoxa9 and Meis1 Are Key Targets for MLL-ENL-Mediated Cellular Immortalization
Zeisig, B. B., Milne, T., García-Cuéllar, M.-P., Schreiner, S., Martin, M.-E., Fuchs, U., Borkhardt, A., Chanda, S. K., Walker, J., Soden, R., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.2.617-628.2004 · Cited by 328
Hematopoietic, angiogenic and eye defects in Meis1 mutant animals
Hisa, T., Spence, S. E., Rachel, R. A., Fujita, M., Nakamura, T., Ward, J. M., Devor‐Henneman, D. E., Saiki, Y., Kutsuna, H., Tessarollo, L., et al. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600038 · Cited by 308
Selleri, L., Depew, M. J., Jacobs, Y., Chanda, S. K., Tsang, K. Y., Cheah, K. S. E., Rubenstein, J. L. R., O’Gorman, S., & Cleary, M. L. (2001) · Development · doi:10.1242/dev.128.18.3543 · Cited by 297
Self-citationPineault, N., Helgason, C. D., Lawrence, H. J., & Humphries, R. K. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00757-3 · Cited by 282
Hanson, R. D., Hess, J. L., Yu, B. D., Ernst, P., van Lohuizen, M., Berns, A., van der Lugt, N. M. T., Shashikant, C. S., Ruddle, F. H., Seto, M., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14372 · Cited by 236
Regulation of Hox target genes by a DNA bound Homothorax/Hox/Extradenticle complex
Ryoo, H. D., Marty, T., Casares, F., Affolter, M., & Mann, R. S. (1999) · Development · doi:10.1242/dev.126.22.5137 · Cited by 229
Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias
Lawrence, H., Rozenfeld, S., Cruz, C., Matsukuma, K., Kwong, A., Kömüves, L., Buchberg, A., & Largman, C. (1999) · Leukemia · doi:10.1038/sj.leu.2401578 · Cited by 222
Interaction of MLL Amino Terminal Sequences with Menin Is Required for Transformation
Caslini, C., Yang, Z., El-Osta, M., Milne, T. A., Slany, R. K., & Hess, J. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2369 · Cited by 214
Lavau, C. (2000) · The EMBO Journal · doi:10.1093/emboj/19.17.4655 · Cited by 203
Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias
So, C. W., Lin, M., Ayton, P. M., Chen, E. H., & Cleary, M. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00188-0 · Cited by 196
Self-citationMilne, T. A., Martin, M. E., Brock, H. W., Slany, R. K., & Hess, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1041 · Cited by 182
Capellini, T. D., Di Giacomo, G., Salsi, V., Brendolan, A., Ferretti, E., Srivastava, D., Zappavigna, V., & Selleri, L. (2006) · Development · doi:10.1242/dev.02395 · Cited by 178
DiMartino, J. F., Selleri, L., Traver, D., Firpo, M. T., Rhee, J., Warnke, R., O'Gorman, S., Weissman, I. L., & Cleary, M. L. (2001) · Blood · doi:10.1182/blood.v98.3.618 · Cited by 174
Self-citationThe specificity of homeotic gene function
Mann, R. S. (1995) · BioEssays · doi:10.1002/bies.950171007 · Cited by 164
Hox regulation of normal and leukemic hematopoietic stem cells
Abramovich, C., & Humphries, R. K. (2005) · Current Opinion in Hematology · doi:10.1097/01.moh.0000160737.52349.aa · Cited by 162
Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9
So, C. W., Karsunky, H., Wong, P., Weissman, I. L., & Cleary, M. L. (2004) · Blood · doi:10.1182/blood-2003-10-3722 · Cited by 160
Self-citationSchnabel, C. A., Jacobs, Y., & Cleary, M. L. (2000) · Oncogene · doi:10.1038/sj.onc.1203371 · Cited by 150
Self-citationThe AF10 leucine zipper is required for leukemic transformation of myeloid progenitors by MLL-AF10
DiMartino, J. F., Ayton, P. M., Chen, E. H., et al. (2002) · Blood · doi:10.1182/blood.v99.10.3780 · Cited by 137
Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia
Kumar, A. R., Hudson, W. A., Chen, W., Nishiuchi, R., Yao, Q., & Kersey, J. H. (2003) · Blood · doi:10.1182/blood-2003-07-2582 · Cited by 130
Wang, G. G., Pasillas, M. P., & Kamps, M. P. (2005) · Blood · doi:10.1182/blood-2004-12-4664 · Cited by 123
Common mechanism for oncogenic activation of MLL by forkhead family proteins
So, C. W. E., & Cleary, M. L. (2002) · Blood · doi:10.1182/blood-2002-06-1785 · Cited by 119
Self-citationWarner, J. K., Wang, J. C. Y., Takenaka, K., Doulatov, S. R., McKenzie, J. L., Harrington, L. A., & Dick, J. E. (2005) · Leukemia · doi:10.1038/sj.leu.2403917 · Cited by 118
Conditional MLL‐CBP targets GMP and models therapy‐related myeloproliferative disease
Wang, J., Iwasaki, H., Krivtsov, A. V., Febbo, P. G., Thorner, A. R., Ernst, P., Anastasiadou, E., Kutok, J. L., Kogan, S. C., Zinkel, S. S., et al. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600521 · Cited by 115
So, C. W. E., & Cleary, M. L. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.18.6542-6552.2002 · Cited by 101
Self-citationCalvo, K. R., Knoepfler, P. S., Sykes, D. B., Pasillas, M. P., & Kamps, M. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231115398 · Cited by 95
Pbx3 Deficiency Results in Central Hypoventilation
Rhee, J. W., Arata, A., Selleri, L., Jacobs, Y., Arata, S., Onimaru, H., & Cleary, M. L. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63392-5 · Cited by 92
Self-citationThe TALE Homeodomain Protein Pbx2 Is Not Essential for Development and Long-Term Survival
Selleri, L., DiMartino, J. F., van Deursen, J., Brendolan, A., Sanyal, M., Boon, E. M. J., Capellini, T. D., Smith, K. S., Rhee, J. W., Pöpperl, H., et al. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5324-5331.2004 · Cited by 92
Self-citationZhang, S., Qian, X., Redman, C., Bliskovski, V., Ramsay, E. S., Lowy, D. R., & Mock, B. A. (2003) · Oncogene · doi:10.1038/sj.onc.1206257 · Cited by 91
The role of HOX genes in malignant myeloid disease
Eklund, E. A. (2007) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32801684b6 · Cited by 88
Imamura, T., Morimoto, A., Takanashi, M., Hibi, S., Sugimoto, T., Ishii, E., & Imashuku, S. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2002.03803.x · Cited by 82
HOX deregulation in acute myeloid leukemia
Rice, K. L., & Licht, J. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31861 · Cited by 76
XMeis3 protein activity is required for proper hindbrain patterning inXenopus laevisembryos
Dibner, C., Elias, S., & Frank, D. (2001) · Development · doi:10.1242/dev.128.18.3415 · Cited by 72
Functional and regulatory interactions between Hox andextradenticle genesPreprint
Azpiazu, N., & Morata, G. (1998) · Genes & Development · doi:10.1101/gad.12.2.261 · Cited by 69
Leukemic Stem Cells: Where do They Come From?
Passegue, E. A., & Weisman, I. L. (2005) · Stem Cell Reviews and Reports · doi:10.1385/scr:1:3:181 · Cited by 61
Expression ofHOXGenes in Acute Leukemia Cell Lines with and withoutMLLTranslocations
Quentmeier, H., Dirks, W. G., MacLeod, R. A. F., Reinhardt, J., Zaborski, M., & Drexler, H. G. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001609942 · Cited by 59
Shah, N., Oseth, L., & LeBien, T. W. (1998) · Blood · doi:10.1182/blood.v92.10.3817 · Cited by 44
The Proportion of Clonal Divisions Varies in Different Hematologic Malignancies
Swansbury, G. J. (1998) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(97)00477-9 · Cited by 5
Cited by
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923
The Hox genes and their roles in oncogenesis
Shah, N., & Sukumar, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2826 · Cited by 835
Menin Critically Links MLL Proteins with LEDGF on Cancer-Associated Target Genes
Yokoyama, A., & Cleary, M. L. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.003 · Cited by 555
Self-citationMenin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia
Grembecka, J., He, S., Shi, A., Purohit, T., Muntean, A. G., Sorenson, R. J., Showalter, H. D., Murai, M. J., Belcher, A. M., Hartley, T., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.773 · Cited by 462
MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
Winters, A. C., & Bernt, K. M. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00004 · Cited by 405
Metadata
- Authors
- Wong, P., Iwasaki, M., Somervaille, T. C. P., So, C. W. E., & Cleary, M. L.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2007-10-17
- Volume
- 21
- Issue
- 21
- Pages
- 2762-2774
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2104910696
- Cited by
- 266
- References
- 53
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.